A Concise Viewpoint on Menopause, Hormone-Replacement Therapy and Breast Cancer Risk

Vaishnavi Natarajan (1), Anindita Chakrabarty (2)
(1) Amity University, Noida, Uttar Pradesh, India, India,
(2) Shiv Nadar University, Greater Noida, Uttar Pradesh, India, India
https://doi.org/10.32768/abc.20218114-15

Article Sidebar

Issue
Vol 8, No 1: February 2021
Submitted
December 16, 2020
Published
January 28, 2021
Keywords:
    Menopause, Hormone replacement therapy (HRT), Estrogen, Progesterone, Breast cancer
PDF XML

Abstract

NA

Full text article

Generated from XML file

References

Bruce D, Rymer J. Symptoms of the menopause. Best practice & research Clinical obstetrics & gynaecology. 2009;23(1):25-32.

Cagnacci A, Venier M. The Controversial History of Hormone Replacement Therapy. Medicina. 2019;55(9):602.

Investigators WGftWsHI. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmeno-pausal WomenPrincipal Results From the Women's Health Initiative Randomized Controlled Trial. JAMA. 2002;288(3):321-33.

Santen RJ. Menopausal hormone therapy and breast cancer. The Journal of steroid biochemistry and molecular biology. 2014;142:52-61.

Santen RJ, Song Y, Yue W, Wang JP, Heitjan DF. Effects of menopausal hormonal therapy on occult breast tumors. The Journal of steroid biochemistry and molecular biology. 2013;137:150-6.

Reid RL. Hormone therapy and breast cancer: risk communication and the 'perfect storm'. Climacteric : The Journal of the International Menopause Society. 2019;22(1):13-6.

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019;394(10204):1159-68.

Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ. 2020;371:m3873.

Nelson HD. Menopause. Lancet (London, England). 2008;371(9614):760-70.

Fait T. Menopause hormone therapy: latest developments and clinical practice. Drugs in context. 2019;8:212551.

Cobin RH, Goodman NF. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause-2017 UPDATE. Endocrine practice : official journal of the American College of Endocrin-ology and the American Association of Clinical Endocrinologists. 2017;23(7):869-80.

Brown S. Shock, terror and controversy: how the media reacted to the Women's Health Initiative. Climacteric : the journal of the International Menopause Society. 2012;15(3): 275-80.

Langer RD, Manson JE, Allison MA. Have we come full circle - or moved forward? The Women's Health Initiative 10 years on. Climacteric : the journal of the International Menopause Society. 2012;15(3):206-12.

Authors

Vaishnavi Natarajan
Amity University, Noida, Uttar Pradesh, India
Anindita Chakrabarty
Shiv Nadar University, Greater Noida, Uttar Pradesh, India
Anindita.ac@gmail.com (Primary Contact)
1.
Natarajan V, Chakrabarty A. A Concise Viewpoint on Menopause, Hormone-Replacement Therapy and Breast Cancer Risk. Arch Breast Cancer [Internet]. 2021 Jan. 28 [cited 2024 Jun. 4];:14-5. Available from: https://www.archbreastcancer.com/index.php/abc/article/view/351
Download Citation
Endnote/Zotero/Mendeley (RIS)

Copyright (c) 2021 Archives of Breast Cancer

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.

Article Details